About YJMED
Shanghai YJMED Biotechnology Co., Ltd. (YJMED) is a national
high-tech enterprise headquartered in Jiading District,
Shanghai, operating over 6,500 square meters of R&D
laboratories and GMP production facilities. Since its founding
in 2021, YJMED has been dedicated to the R&D and manufacturing
of gene sequencing systems and upstream molecular diagnostic
technology platforms.
YJMED's core products include the high-throughput gene
sequencer Yjseq300 and the Libcap automated library
preparation/capture workstation, both designed to support the
operational needs of genetic testing service providers and
life science research institutions worldwide.
As a wholly-owned subsidiary of Shanghai Yijian Health Technology
Co., Ltd., YJMED benefits from a broader precision medicine
ecosystem. The Group's subsidiaries — including Shanghai Yijian
Medical Laboratory Co., Ltd. and Ruijian (Shanghai) Software
Technology Co., Ltd. — specialize in precision medical services
and digital laboratory management, enabling YJMED to deliver
integrated solutions that span from instrumentation to downstream
data and service applications.
Ruijian Software:the Group's digital infrastructure
arm, provides the LIMS system and "Yijian Cloud" service platform.
The LIMS system supports fully customized deployment for
traditional laboratories and medical testing institutions,
generating 10,000 test reports within 26 seconds. "Yijian Cloud"
further extends this capability into a unified information network
connecting operational, clinical, and end-user layers —
reinforcing the Group's position in the precision medicine
industry.